http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2615866-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17a6b7cbeb60a9b55cbce616134454b1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H39-00
filingDate 2016-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cbc410332a4ba8ebe9933bd83a39139
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11e966b7c2906fb7f3b87e761cacc607
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fec9bc13ef1360ba3a0902d78ba79bfc
publicationDate 2017-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2615866-C1
titleOfInvention Method for chronic migraine treatment
abstract FIELD: medicine. n SUBSTANCE: acupuncture is carried out for 10 sessions a day, lasting 40-45 minutes. Sessions are held against a trance guidance with suggestion of rest and relaxation in the supine position. Thus, depending on the session, neutral, sedative and/or stimulating method is used to affect a specific set of biologically active points (BAP) in accordance with the claims. Moreover, BAP exposure during each session is carried out simultaneously from both sides of the body, and additional exposure is provided for BAT, selected depending on primary headache localization - in forehead, temporal, parietal region diffuse headache areas. At the end of each session, the patient is returned from the trance state. n EFFECT: reduced frequency and intensity of chronic migraine with achievement clinically significant results after 4 weeks, reduced number of used analgesics. n 5 cl, 4 ex, 5 tbl
priorityDate 2016-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2321387-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743214
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID72341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534377
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID72341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415818389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID117909

Total number of triples: 27.